May 10 |
Karyopharm Therapeutics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
May 9 |
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q1 2024 Earnings Call Transcript
|
May 9 |
Karyopharm Therapeutics Inc (KPTI) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
|
May 9 |
Q1 2024 Karyopharm Therapeutics Inc Earnings Call
|
May 8 |
Karyopharm Therapeutics (KPTI) Q1 2024 Earnings Call Transcript
|
May 8 |
Karyopharm to Participate at the 2024 RBC Capital Markets Global Healthcare Conference
|
May 8 |
Karyopharm Therapeutics Inc. (KPTI) Q1 2024 Earnings Call Transcript
|
May 8 |
Karyopharm announces significant refinancing transactions
|
May 8 |
Karyopharm Therapeutics Reports Q1 2024 Financial Results: A Detailed Review
|
May 8 |
Karyopharm Therapeutics GAAP EPS of -$0.32 beats by $0.03, revenue of $33.13M misses by $1.34M
|